Uzbekistan is rapidly consolidating its position as one of the most promising pharmaceutical markets in Eurasia, combining strong economic growth, proactive state policy, and a clear strategic pivot ...
Ardena, a specialist pharmaceutical CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, announced the appointments of Ben Ash as chief financial officer and Henny ...
MedVital Ventures raises Rs. 18 cr led by Alkemi Growth Capital to scale medical technolgies in advanced wound care and regenerative aesthetics: Our Bureau, Mumbai Wednesday, May ...
Prolacta Bioscience’s JASMINE trial shows human milk-based fortifiers deliver superior growth in premature infants while maintaining Japan’s renowned low NEC rate: Duarte, Cal ...
Altesa BioSciences begins enrolment in phase 2b CARDINAL trial of vapendavir as transformational treatment for patients with COPD impacted by rhinovirus: Atlanta ...
Egetis Therapeutics’ MCT8 deficiency composition receives US patent: Stockholm, Sweden Wednesday, May 6, 2026, 16:00 Hrs [IST] Egetis Therapeutics AB (publ) (Egetis), an innovat ...
SS Innovations International conducts long distance telesurgery between Australia and India: Our Bureau, Bengaluru Wednesday, May 6, 2026, 14:30 Hrs [IST] SS Innovations Internati ...
Even Healthcare gets IRDAI nod to launch Retail Health Insurance; enabling policy portability for customers: Our Bureau, Bengaluru Wednesday, May 6, 2026, 13:45 Hrs [IST] Even Hea ...
Anuh Pharma has received prequalification approval from World Health Organization (WHO) for anti-malarial active pharmaceutical ingredient (API) amodiaquine hydrochloride USP, the company said in its ...
Digital healthcare platform PharmEasy, one of the major e-pharmacy companies in the country, has announced launch of its online physiotherapy service. Through the new service, the company offers ...
Merck, known as MSD outside of the United States and Canada, announced the successful completion of the acquisition of Terns Pharmaceuticals, Inc. (Terns). “The Terns acquisition reflects Merck’s ...
Alloy Therapeutics and Institute for Protein Innovation collaborate to advance next-generation antibody discovery: Boston Wednesday, May 6, 2026, 15:00 Hrs [IST] Alloy Therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results